• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌放疗后急性与晚期胃肠道毒性关系的系统评价

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer.

作者信息

Peach Matthew Sean, Showalter Timothy N, Ohri Nitin

机构信息

Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA.

出版信息

Prostate Cancer. 2015;2015:624736. doi: 10.1155/2015/624736. Epub 2015 Nov 30.

DOI:10.1155/2015/624736
PMID:26697225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677238/
Abstract

A small but meaningful percentage of men who are treated with external beam radiation therapy for prostate cancer will develop late gastrointestinal toxicity. While numerous strategies to prevent gastrointestinal injury have been studied, clinical trials concentrating on late toxicity have been difficult to carry out. Identification of subjects at high risk for late gastrointestinal injury could allow toxicity prevention trials to be performed using reasonable sample sizes. Acute radiation therapy toxicity has been shown to predict late toxicity in several organ systems. Late toxicities may occur as a consequential effect of acute injury. In this systematic review of published reports, we found that late gastrointestinal toxicity following prostate radiotherapy seems to be statistically and potentially causally related to acute gastrointestinal morbidity as a consequential effect. We submit that acute gastrointestinal toxicity may be used to identify at-risk patients who may benefit from additional attention for medical interventions and close follow-up to prevent late toxicity. Acute gastrointestinal toxicity could also be explored as a surrogate endpoint for late effects in prospective trials.

摘要

一小部分但有意义比例的接受前列腺癌外照射放疗的男性会出现晚期胃肠道毒性。虽然已经研究了许多预防胃肠道损伤的策略,但专注于晚期毒性的临床试验很难开展。识别晚期胃肠道损伤高危受试者可以使毒性预防试验在合理的样本量下进行。急性放射治疗毒性已被证明可预测多个器官系统的晚期毒性。晚期毒性可能是急性损伤的继发效应。在对已发表报告的这项系统评价中,我们发现前列腺放疗后的晚期胃肠道毒性似乎在统计学上与作为继发效应的急性胃肠道发病率存在潜在因果关系。我们认为,急性胃肠道毒性可用于识别可能从额外医疗干预关注和密切随访中受益以预防晚期毒性的高危患者。急性胃肠道毒性也可在前瞻性试验中作为晚期效应的替代终点进行探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da9e/4677238/cbc6f01fb475/PC2015-624736.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da9e/4677238/cbc6f01fb475/PC2015-624736.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da9e/4677238/cbc6f01fb475/PC2015-624736.001.jpg

相似文献

1
Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer.前列腺癌放疗后急性与晚期胃肠道毒性关系的系统评价
Prostate Cancer. 2015;2015:624736. doi: 10.1155/2015/624736. Epub 2015 Nov 30.
2
Rectal/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis.高危前列腺癌患者接受低分割与常规分割放疗后的直肠/泌尿毒性:系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2017 Aug;21(16):3563-3575.
3
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.前列腺癌放射治疗后的盆腔并发症及其处理:国际协作叙事性综述。
Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17.
4
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.对于前列腺癌患者,采用低分割与常规分割放射治疗(HYPRO):一项随机、非劣效性、3 期试验的晚期毒性结果。
Lancet Oncol. 2016 Apr;17(4):464-474. doi: 10.1016/S1470-2045(15)00567-7. Epub 2016 Mar 9.
5
Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.低/中危局限性前列腺癌患者接受大分割放疗与传统放疗后的直肠/泌尿毒性:系统评价与荟萃分析
Oncotarget. 2017 Mar 7;8(10):17383-17395. doi: 10.18632/oncotarget.14798.
6
Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.近距离放射治疗联合外照射放疗用于局限性前列腺癌:采用术中近距离放射治疗计划技术和补充调强放射治疗可降低发病率
Brachytherapy. 2008 Jan-Mar;7(1):1-6. doi: 10.1016/j.brachy.2007.12.002.
7
Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.适形同期调强放疗推量治疗高危前列腺癌:晚期毒性。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):898-905. doi: 10.1016/j.ijrobp.2010.11.003. Epub 2011 Jan 14.
8
Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial.中高危局限性前列腺癌(THEPCA)患者高剂量率近距离放疗联合外照射放疗的时机及其对毒性和生活质量的影响:一项随机可行性试验方案
JMIR Res Protoc. 2015 Apr 29;4(2):e49. doi: 10.2196/resprot.4462.
9
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.RTOG 二期临床试验(00-19)的长期结果:外照射放疗联合永久性放射性源近距离治疗局部中危局限性前列腺腺癌。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e795-801. doi: 10.1016/j.ijrobp.2011.11.040. Epub 2012 Feb 11.
10
Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.前列腺癌外照射治疗后的毒性:糖尿病男性患者迟发性发病分析。
Urology. 2013 Jun;81(6):1196-201. doi: 10.1016/j.urology.2013.01.047. Epub 2013 Mar 26.

引用本文的文献

1
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.同步整合加量(SIB)的中度低分割放疗用于(极)高危前列腺癌的5年生存率和毒性的前瞻性研究结果
Clin Transl Radiat Oncol. 2023 Nov 17;44:100702. doi: 10.1016/j.ctro.2023.100702. eCollection 2024 Jan.
2
Rectum and Bladder Toxicity in Postoperative Prostate Bed Irradiation: Dose-Volume Parameters Analysis.术后前列腺床照射中的直肠和膀胱毒性:剂量-体积参数分析
Cancers (Basel). 2023 Nov 9;15(22):5334. doi: 10.3390/cancers15225334.
3
Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis.

本文引用的文献

1
Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer.局部前列腺癌高强度调强放疗后 54 个月生活质量的前瞻性评估。
Radiat Oncol. 2013 Mar 6;8:53. doi: 10.1186/1748-717X-8-53.
2
Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.用于降低前列腺放射治疗中直肠剂量的间质可生物降解球囊:基于国际多中心研究的植入前和植入后成像数据的虚拟计划研究结果。
Radiother Oncol. 2013 Feb;106(2):210-4. doi: 10.1016/j.radonc.2013.01.007. Epub 2013 Feb 26.
3
前列腺癌中度低分割放疗的急性和晚期毒性模式:一项系统评价和荟萃分析。
Clin Transl Radiat Oncol. 2023 Mar 17;40:100612. doi: 10.1016/j.ctro.2023.100612. eCollection 2023 May.
4
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.急性与晚期泌尿生殖系统及胃肠道毒性之间的关联:PACE B研究分析
Cancers (Basel). 2023 Feb 17;15(4):1288. doi: 10.3390/cancers15041288.
5
Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer.TGFB1、XRCC1、XRCC3 基因多态性与 CD8 T 淋巴细胞凋亡与前列腺癌放疗不良反应的关系。
Sci Rep. 2022 Dec 9;12(1):21306. doi: 10.1038/s41598-022-25328-6.
6
Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study.锥形束 CT 德尔塔放射组学预测前列腺癌患者泌尿生殖系统毒性和国际前列腺症状:一项初步研究。
Sci Rep. 2022 Nov 22;12(1):20136. doi: 10.1038/s41598-022-24435-8.
7
Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer.针对接受高危前列腺癌放疗的男性,计划剂量与累积剂量的剂量-体积分析作为晚期胃肠道毒性预测指标的研究
Phys Imaging Radiat Oncol. 2022 Jul 16;23:97-102. doi: 10.1016/j.phro.2022.07.001. eCollection 2022 Jul.
8
Impact of Pelvic Radiation Therapy for Prostate Cancer on Global Metabolic Profiles and Microbiota-Driven Gastrointestinal Late Side Effects: A Longitudinal Observational Study.前列腺癌盆腔放疗对全球代谢特征及菌群驱动的胃肠道晚期副作用的影响:一项纵向观察性研究。
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1204-1213. doi: 10.1016/j.ijrobp.2021.07.1713. Epub 2021 Aug 2.
9
Effect of patient thickness on acute gastrointestinal toxicities following radiotherapy for prostate cancer.患者体型对前列腺癌放疗后急性胃肠道毒性的影响。
Rep Pract Oncol Radiother. 2021 Jun 9;26(3):352-359. doi: 10.5603/RPOR.a2021.0053. eCollection 2021.
10
Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production.罗格列酮通过抑制 NLRP3 炎性体和 TNF-α 的产生来改善大鼠放射性肠炎。
J Radiat Res. 2020 Nov 16;61(6):842-850. doi: 10.1093/jrr/rraa062.
Gastrointestinal radiation injury: prevention and treatment.
胃肠道放射性损伤:预防与治疗。
World J Gastroenterol. 2013 Jan 14;19(2):199-208. doi: 10.3748/wjg.v19.i2.199.
4
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.前瞻性评估水凝胶 spacer 在临床局限性前列腺癌调强放疗中直肠分离的效果。
BMC Cancer. 2013 Jan 22;13:27. doi: 10.1186/1471-2407-13-27.
5
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.系统评价癌症患者胃肠道黏膜炎管理中的药物。
Support Care Cancer. 2013 Jan;21(1):313-26. doi: 10.1007/s00520-012-1644-z. Epub 2012 Nov 10.
6
Role of early proctoscopy in predicting late symptomatic proctitis after external radiation therapy for prostate carcinoma.早期直肠镜检查在外照射治疗前列腺癌后预测迟发性症状性直肠炎的作用。
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1031-7. doi: 10.1016/j.ijrobp.2012.07.2373. Epub 2012 Sep 11.
7
Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review.慢性放射性直肠炎的内镜和药物治疗:系统评价。
Dis Colon Rectum. 2012 Oct;55(10):1081-95. doi: 10.1097/DCR.0b013e3182587aef.
8
Late toxicity rates following definitive radiotherapy for prostate cancer.前列腺癌根治性放疗后的迟发性毒性发生率
Can J Urol. 2012 Aug;19(4):6373-80.
9
Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study.我们能否在前列腺癌患者放疗期间使用透明质酸来减少急性直肠炎:一项前瞻性历史对照临床研究。
Eur Rev Med Pharmacol Sci. 2012 May;16(5):639-45.
10
Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.应用间隔凝胶优化前列腺癌的三维适形和调强放疗。
Radiother Oncol. 2011 Sep;100(3):436-41. doi: 10.1016/j.radonc.2011.09.005. Epub 2011 Sep 29.